Pro-inflammatory effect of oestrogens

Fibrinolysis and Proteolysis

Volumn 13, Issue 6, 1999, Pages 217-219

  Kluft, C ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ACUTE PHASE RESPONSE; CARDIOVASCULAR DISEASE; EDITORIAL; ESTROGEN ACTIVITY; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 0033510619     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1054/fipr.2000.0045     Document Type: Editorial

References (30)

1. M. Frohlich A. Doring A. Imhof W.L. Hutchinson M.B. Pepys W. Koenig Oral contraceptive use is associated with a systematic acute phase response Fibrinolysis Proteolysis 13(6) 1999 239 244
2. P.M. Ridker C.H. Hennekens N. Rifai J.E. Buring J.E. Manson Hormone replacement therapy and increased plasma concentration of C-reactive protein Circulation 100 1999 713 716
3. M. Cushman C. Legault E. Barrett-Connor Effect of postmenopausal hormones on inflammation-sensitive proteins The postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 100 1999 717 722
4. M.P.M. De Maat F. Haverkate C. Kluft C-reactive protein: a cardiovascular risk factor Fibrinolysis Proteolysis 12 1998 323 327
5. C. Kluft J.A. Gevers Leuven F.M. Helmerhorst H.M.J. Krans Oestrogens and insulin resistance are the main determinants of C-reactive protein in blood Fibrinolysis Proteolysis 13 (suppl 1) 1999 50
6. M.W. Van Baal P. Kenemans M.J. Van der Mooren H. Kessel J.J. Emeis C.D.A. Stehouwer Increased C-reactive protein level during short-term hormone replacement therapy in healthy postmenopausal women Thromb Haemost 81 1999 925 928
7. Roo De Valk-de C.D.A. Stehouwer P. Meijer Both Raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women A 2-year, placebo-controlled study. Arterioscler Thromb Vasc Biol 19 1999 2993 3000
8. N. Sattar M. Perera M. Small M.A. Lumsden Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes Lancet 354 1999 487 488
9. P.M. Ridker M. Cushman M.J. Stampfer R.P. Tracy C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
10. P.W. Kamphuisen J.C. Eikenboom H.L. Vos Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions Thromb Haemost 81 1999 680 683
11. P.M. Ridker N. Rifai M.A. Pferrer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
12. P.M. Ridker N. Rifai M.A. Pfeffer F. Sacks E. Braunwald Long-term effects of pravastatin on plasma concentration of C-reactive protein. The cholesterol and recurrent events (CARE) investigators Circulation 100 1999 230 235
13. T.E. Strandberg H. Vanhanen M.J. Tikkanen Effect of statins on C-reactive protein in patients with coronary artery disease Lancet 353 1999 118 119
14. C. Kluft M.P.M. De Maat J.A. Gevers Leuven B.J. Potter van Loon Mohrschladt Statins and C-reactive protein Lancet 353 1999 1274
15. R.S. Rosenson C.C. Tangney L.C. Casey Inhibition of proinflammatory cytokine production by pravastatin Lancet 353 1999 983 984
16. D. Ferro S. Basili C. Alessandri B. mantovani C. Cordova F. Violi Simvastatin reduces monocyte-tissue-factor expression in type IIa hypercholesterolaemia Lancet 350 1997 1222
17. U. Ikeda K. Shimada Statins and monocytes Lancet 353 1999 2070
18. T. Caulin-Glazer W.J. Farrell S.E. Pfau Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease JACC 31 1998 1555 1560
19. W.M. Van Baal J.J. Emeis P. Kenemans Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules Eur J Clin Invest 29 1999 913 921
20. S.C. Lim A.E. Caballero S. Arora The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes J Clin Endocrinol Metab 84 1999 4159 4164
21. K.K. Koh A. Blum L. Hathaway Vascular effects of estrogen and vitamin E therapy in postmenopausal women Circulation 100 1999 1851 1857
22. W.M. Van Baal P. Kenemans J.J. Emeis Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women Fertil Steril 71 1999 663 670
23. P.Y. Scarabin M. Alhenc-Gelas E. Oger G. Plu-Bureau Hormone replacement therapy and circulating ICAM-1 in postmenopausal women-a randomised controlled trial Thromb Haemost 81 1999 673 675
24. C. Gabay I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454
25. J. Cermak N.S. Key R.R. Bach J. Balla H.S. Jacob G.M. Vercellotti C-reactive protein induces human peripheral blood monocyte to synthesize tissue factor Blood 82 1993 513 520
26. M. Ramani F. Khechia V. Ollivier Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes FEBS lett 356 1994 86 88
27. W.K. Lagrand C.A. Visser W.T. Hermens C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 100 1999 96 102
28. M. Griselli J. Herbert W.L. Hutchinson Creative protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 1999 1733 1740
29. G. Liuzzo A. Buffon L.M. Biasucci Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina Circulation 98 1998 2370 2376
30. J. Whicher L. Biasucci N. Rifai Inflammation, the acute phase response and atherosclerosis Clin Chem Lab Med 37 1999 495 503